Question explored with the scientific record
Conversation so far
- 1 What are the benefits of viewing red light at 670nm
- 2 Are there any human studies on 670 nm eye exposure specifically?
Answered on this page ↓
Are there any human studies on 670 nm eye exposure specifically?
The short version: yes, human trials of 670 nm light reaching the eye exist, but none of the 14 records here is one of them.
I have to correct my last answer. I said the records contained no human trial of viewing 670 nm light. That was true of that search. It is not true of the world: human studies of red and near-infrared light aimed at the eye do exist outside this retrieval, and I cannot confirm their specifics from memory. What I can say is that this search still did not surface one.
What it did surface is skin, not eyes. A 2026 scoping review of red and near-infrared light for scars includes a randomized split-scar trial in children using 633–670 nm LED, with better scar scores than untreated areas and no reported adverse events [1]. A second trial used 670 nm on adult burn scars and reported improvement [1]. Both are light on skin, not light viewed by the eye, and both are small [1].
The safety picture for light therapy generally is not empty. A systematic review of photobiomodulation in cancer patients found no sign that it worsened tumor outcomes at recommended doses, though very high doses stimulated melanoma growth in one mouse model [2]. That is a caution about dose, not a verdict on eye exposure.
| Record | Subject | Wavelength | Relevance to eye |
|---|---|---|---|
| [1] | Children, burn scars | 633–670 nm | Skin only |
| [1] | Adults, burn scars | 670 nm | Skin only |
| [2] | Cancer patients, animals | 660–830 nm | Not eye |
My call: human eye studies of 670 nm almost certainly exist outside this retrieval, but nothing in front of me tests viewing it, so I cannot tell you what they found. Confidence: low.
Sources used 2
-
Red and near-infrared photobiomodulation for burn, hypertrophic, and post-surgical scars: a scoping review of clinical trials
Red and near-infrared photobiomodulation using LED or LLLT shows wavelength- and dose-dependent improvements in burn, hypertrophic, and post-surgical scars with good safety, but current evidence is limited by small, heterogeneous trials and lack of standardized dosing.
DOI: 10.1007/s10103-026-04875-8 -
Safety and efficacy of photobiomodulation therapy in oncology: A systematic review
In a PRISMA systematic review of 43 in vitro, 15 in vivo, and 9 clinical studies, photobiomodulation therapy appears safe with recommended parameters in clinical and animal studies, while in vitro findings on tumor-cell proliferation are conflicting.
DOI: 10.1002/cam4.3582